SINTOCEF IM 1F 1G F 2,5 ML SOLV
Active CEFONICID SODIUM
Group therapy OTHER beta-lactam antibacterial
Product Type DRUG-FREE NHS scheme ETHICS FOR DISEASE
Class A Recipe Type RR - Repeat
Form Farm. INJECTIONS Container BOX
Date Commerc life 18 months. Price
ATC J01DC06
prescribing MULTIPRESCRIVIBILE (6 PIECES MAXIMUM FOR RECIPE)
The product contains no gluten, gluten
Manufacturer & BONISCONTRO Gazzoni Srl
Pharmacotherapeutic
antibacterial beta-lactam. INDICATIONS
use in specific elective and severe bacterial infections of confirmed or suspected source
Gram-negative "difficult" or mixed flora with
presence of gram-negative Sintocef sensitive and resistant to most 'co muni
antibiotics. In particular, the product is indicated for s
uddette infections in debilitated patients and / or immunocompromised.
SURGICAL PROPHYLAXIS: Administration of a single dose of 1 gram of first
ll'intervento surgery reduces the incidence of post-operative infections
ie germ-sensitive patients undergoing surgery
classified as contaminated or potentially contaminated, or pazie
nts in presenting a real risk of infection at the site of the Inter
wind, providing protection from infection during the period
intervention and for a period of about 24 hours after the sum
inistrazione. Additional doses can be given for further
than two days to patients undergoing arthroplasty
with implants. The intraoperative administration (after ligation of the umbilical cord
) reduces the incidence of postoperative sepsis cons
eguenti to Caesarean section.
CONTRAINDICATIONS / EFF.SECONDAR
Individuals who have already 'demonstrated hypersensitivity' vers
or other cephalosporins. PREGNANCY. In women pregnant
the product should be administered in cases of real need ', under the direct control
doctor, carefully assessing the possible vant
Agios respect to any risk. Labor e parto: in caso di tag
lio cesareo, puo' essere somministrato soltanto dopo la legatura del c
ordone ombelicale. ALLATTAMENTO: e' escreto nel latte umano in concent
razioni basse. Dovrebbero essere adottate delle precauzioni volendo so
mministrare durante il periodo dell'allattamento.
POSOLOGIA
ADULTI. In genere il dosaggio per l'adulto e' di 1 g somministrato in_
dose singola giornaliera ogni 24 ore per via intramuscolare profonda.
Dosi giornaliere superiori a 1 g sono raramente necessarie. Comunque i
n casi eccezionali dosi fino a 2 grammi in un'unica somministrazione s
ono state ben tollerate. Dovendo somministrare 2 grammi intramuscolo i
n un'unica daily dose, half 'of this dose should be somm
inistrata in a different muscle. Renal failure. In pa tients with
function 'impaired kidney and' the need to change some of
sologia Sintocef. After an initial loading dose of 7.5 mg / kg int
ramuscolo maintenance doses should be adjusted according to the t
abella below. Additional doses should be
indic ate \u200b\u200bthe therapeutic monitoring, the severity 'of the infection and by
sensitivity' of the microorganism responsible for infection. ADULT
with reduced 'KIDNEY. Less serious infections: 79-60
every 24 hours - Infections at high risk: 10 mg / kg every 24 hours Dose = ml / m
in.x 1.73 m2: 25 mg / kg, 59-40 per 24 hours - 8 mg / kg every 24 hours = 20 m
g / kg, 39-20 per 24 hours - 4 mg / kg every 24 hours = 15 mg / kg every 4 19-10
8 hours - 4 mg / kg every 48 hours = 15 mg / kg; 9-5 - 4 mg / kg every 3-5 days
= 15 mg / kg every 3-5 days; < 5 - 3 mg/kg ogni 3-5 gg = 4 mg/kg ogni 3-5 gg. I
n the course of dialysis do not need additional doses.
CHILDREN. Sintocef is administered intramuscularly or iv
lla in a single daily dose of 50 mg / kg.
INTERACTIONS
In case of concomitant administration of nephrotoxic drugs (which
the aminoglycosides, colistin, etc..) Functionality '
impairment should be closely controlled.
SIDE EFFECTS
Side reactions have occurred rarely. Indesiderat
reactions and occurring in greater than 1% are:
phenomena at the site of injection (5.7%), pain on injection and less frequent
LY burning and phlebitis at the site of iv Increase
of platelets (1.7%). Transient increases in eosinophils (2.9%). Alterations
ions function tests' liver (1.6%), increased the alkaline phosphatase
, SGOT, SGPT, GGTP, LDH. Adverse reactions that manifest
Stan in less than 1% of patients treated are: hypersensitivity reactions
ible ', fever, skin rash, itching, rash, myalgia and
the reactions of anaphylaxis. Hematology: decreased WBC, neutropenia.
and Diarra. Pseudomembranous colitis have been reported following the use of
cephalosporins (and other broad-spectrum antibiotics), however, and 'set
rtante consider this diagnosis in patients who experience
Diarra after the use of antibiotic. Treatment with antibiotics in large sp
ettro alters the normal flora of the colon and can 'afford an excessive development
Clostridia. Studies show that a toxin produced by C
lostridium difficult and 'the primary cause of colitis due to antibiotics
ico. Mild cases of colitis may heal
following the interruption of therapy. Cases moderate to severe
should be treated with fluids and electrolytes as indicated. When the colitis does not improve the c
on drug discontinuation or when it is 'severe, the treatment of LTA and sce
' oral vancomycin. There have been reports
ia hemolytic anemia following treatment with cephalosporins.
0 comments:
Post a Comment